• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Simulations Plus Inc.

    3/6/24 4:07:11 PM ET
    $SLP
    EDP Services
    Technology
    Get the next $SLP alert in real time by email
    S-8 1 slp-sx8xadditionalsharesre.htm S-8 Document

    As filed with the Securities and Exchange Commission on March 6, 2024

    Registration No. 333-

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    ____________
    FORM S-8
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933
    ____________
    slp_toplogo.gif
    SIMULATIONS PLUS, INC.
    (Exact name of registrant as specified in its charter)
    ____________
    California95-4595609
    (State or other jurisdiction of incorporation)(I.R.S. Employer Identification No.)
    42505 10th Street West
    Lancaster, California 93534-7059
    (Address of principal executive offices) (Zip Code)
    ____________

    SIMULATIONS PLUS, INC. 2021 EQUITY INCENTIVE PLAN
    (Full title of the plan)
    ____________

    Shawn O’Connor
    Simulations Plus, Inc.
    42505 10th Street West
    Lancaster, CA 93534-7059
    661-723-7723
    (Name, address, and telephone number, including area code, of agent for service)
    ____________

    Copies to:

    Dennis J. Doucette, Esq.
    Procopio, Cory, Hargreaves & Savitch LLP
    12544 High Bluff Drive, Suite 400
    San Diego, CA 92130
    (858) 720-6300

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated Filer
    ☒
    Accelerated Filer
    ☐
    Non-accelerated Filer
    ☐
    Smaller reporting company
    ☐
    Emerging Growth Company
    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act ☐
    1


    REGISTRATION OF ADDITIONAL SHARES PURSUANT TO GENERAL INSTRUCTION E

    Pursuant to General Instruction E of Form S-8, Simulations Plus, Inc. (the “Company”) is filing this Registration Statement on Form S-8 (this “Registration Statement”) to register an additional 1,200,000 shares of Company common stock, par value $0.001 per share (“Common Stock”), for issuance under the Company’s 2021 Equity Inventive Plan (the “Original Plan”), as amended by that First Amendment to 2021 Equity Incentive Plan, dated February 9, 2023 (the “First Amendment”), and that Second Amendment to 2021 Equity Incentive Plan, dated February 8, 2024 (together with the Original Plan and the First Amendment, the “Plan”). Such additional shares of Common Stock are in addition to the 1,300,000 shares of Common Stock registered on the Company’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission (the “Commission”) on August 11, 2021 (Commission File No. 333-258711), the contents of which are hereby incorporated by reference into this Registration Statement, except to the extent supplemented, amended or superseded by the information set forth in this Registration Statement.


    PART II
    INFORMATION REQUIRED IN REGISTRATION STATEMENT

    Item 3. Incorporation of Documents by Reference.

    The following documents, which have been filed by the Company with the Commission, are incorporated herein by reference:

    •The Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2023, filed with the Commission on October 27, 2023;

    •The Company’s Definitive Schedule 14A Proxy Statement, filed with the Commission on December 22, 2023;

    •The Company’s Quarterly Report on Form 10-Q, filed with the Commission on January 5, 2024;

    •The Company’s Current Reports on Form 8-K, filed with the Commission on November 1, 2023, January 3, 2024 and February 12, 2024; and

    •The description of the Company’s Common Stock contained in the Company’s Registration Statements filed with the Commission under the Exchange Act, including any amendments or reports filed for the purposes of updating such descriptions, including without limitation the Company’s Registration Statement on Form 8-A (File Number 001-32046) filed with the Commission on March 16, 2004, as subsequently amended, and Exhibit 4.3 to the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2023, filed with the Commission on October 27, 2023.

    All reports and other documents filed by the Company pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that relate to such items, after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this Registration Statement from the date of filing such reports and documents.

    Any statement contained in a document incorporated by, or deemed incorporated by reference herein, shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.
    2


    Item 8    Exhibits
    4.1
    Articles of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K filed on November 29, 2010).
    4.2
    Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.2 to the Company’s Annual Report on Form 10-K filed on November 29, 2010).
    4.3
    Certificate of Amendment to the Amended and Restated Bylaws of Simulations Plus, Inc. (incorporated by reference to Appendix A to the Company’s Definitive Schedule 14A filed on December 31, 2018).
    4.4Form of Common Stock Certificate (incorporated by reference to the Company’s Registration Statement on Form SB-2 (Registration No. 333-6680) filed on March 25, 1997).
    4.5Share Exchange Agreement (incorporated by reference to the Company’s Registration Statement on Form SB-2 (Registration No. 333-6680) filed on March 25, 1997).
    5.1*  
    Opinion of Procopio, Cory, Hargreaves & Savitch LLP.
    23.1*  
    Consent of Rose, Snyder & Jacobs, LLP, independent registered public accounting firm.
    23.2*
    Consent of Procopio, Cory, Hargreaves & Savitch LLP (incorporated by reference to Exhibit 5.1 to this Registration Statement on Form S-8).
    24.1*Power of Attorney (included on the signature page hereto).
    99.1
    Simulation Plus, Inc. 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 8, 2021).
    99.2
    First Amendment to 2021 Equity Incentive Plan of Simulations Plus, Inc., dated February 9, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on February 13, 2023).
    99.3
    Second Amendment to 2021 Equity Incentive Plan of Simulations Plus, Inc., dated February 8, 2024 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on February 12, 2024).
    107*
    Filing Fee Table

    * Filed herewith.










    3


    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Lancaster, State of California, on March 6, 2024.
    SIMULATIONS PLUS, INC.
    By: /s/ Shawn O’Connor
    Shawn O’Connor
    Chief Executive Officer

    POWER OF ATTORNEY

    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Shawn O’Connor and Will Frederick, or either of them, as his or her true and lawful attorneys-in-fact and agent with the full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to file and sign any and all amendments to this Registration Statement, including any and all post-effective amendments, and to file such amendments thereto, with exhibits thereto and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or her substitutes, may lawfully do or cause to be done by virtue hereof.

    ***

    Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the capacities and on the dates indicated.

    SignatureTitleDate
    /s/ Shawn O’Connor
    Chief Executive Officer
    (Principal Executive Officer)
    March 6, 2024
    Shawn O’Connor
    /s/ Will Frederick
    Chief Financial Officer and Chief Operating Officer (Principal Financial and Accounting Officer)
    March 6, 2024
    Will Frederick
    /s/ Walter S. Woltosz
    Chairman of the Board of Directors

    March 6, 2024
    Walter S. Woltosz
    /s/ Dr. Lisa LaVange
    Director
    March 6, 2024
    Dr. Lisa LaVange
    /s/ Dr. Daniel Weiner
    Director
    March 6, 2024
    Dr. Daniel Weiner
    /s/ Sharlene Evans
    Director
    March 6, 2024
    Sharlene Evans
    /s/ Dr. John K. Paglia
    Director
    March 6, 2024
    Dr. John K. Paglia
    4
    Get the next $SLP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SLP

    DatePrice TargetRatingAnalyst
    12/18/2025Buy → Neutral
    BTIG Research
    9/30/2025$16.00Hold
    TD Cowen
    7/15/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    11/15/2024$39.00Overweight
    Stephens
    7/29/2024$47.00Overweight
    KeyBanc Capital Markets
    7/16/2024Mkt Perform
    JMP Securities
    6/28/2024Outperform
    William Blair
    5/9/2023$55.00Buy
    BTIG Research
    More analyst ratings

    $SLP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Woltosz Walter S was granted 1,776 shares, increasing direct ownership by 0.05% to 3,280,683 units (SEC Form 4)

    4 - Simulations Plus, Inc. (0001023459) (Issuer)

    2/2/26 4:18:28 PM ET
    $SLP
    EDP Services
    Technology

    Director Evans Sharlene was granted 1,776 shares, increasing direct ownership by 13% to 15,056 units (SEC Form 4)

    4 - Simulations Plus, Inc. (0001023459) (Issuer)

    2/2/26 4:12:12 PM ET
    $SLP
    EDP Services
    Technology

    Director Weiner Daniel L was granted 1,776 shares, increasing direct ownership by 14% to 14,430 units (SEC Form 4)

    4 - Simulations Plus, Inc. (0001023459) (Issuer)

    2/2/26 4:09:50 PM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Simulations Plus to Participate in Upcoming Investor Conferences

    Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus", "SLP"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that Shawn O'Connor, Chief Executive Officer, will be participating in the upcoming investor conferences: BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference Format: One-on-one meetings When: Tuesday, February 10, 2026 Location: Snowbird, Utah TD Cowen 46th Annual Health Care Conference Format: Fireside chat and one-on-one meetings When: Tuesday, March 3, 2026 Location: Boston, Massachusetts KeyBanc Healthcare Forum Format: Fireside chat and one-on-one meetings When: W

    2/3/26 4:05:00 PM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day

    Showcases platform momentum, strategic priorities, and long-term value creation outlook Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today hosted its 2026 Virtual Investor Day, outlining how the Company is advancing an integrated, AI-enabled platform to support the evolving needs of the drug development industry and its regulators. The Investor Day presentation focused on how Simulations Plus is driving innovation and leading meaningful change across the drug development lifecycle—pairing its long-standing scientific reputation with modern cloud and AI

    1/21/26 4:05:00 PM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Reports First Quarter Fiscal 2026 Financial Results

    Investor Day on January 21, 2026, to present new product vision and AI solutions Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported financial results for its first quarter fiscal 2026, ended November 30, 2025. First Quarter 2026 Financial Highlights (as compared to first quarter 2025) Total revenue decreased 3% to $18.4 million Software revenue decreased 17% to $8.9 million, representing 48% of total revenue Services revenue increased 16% to $9.5 million, representing 52% of total revenue Gross profit was $10.9 million and gross mar

    1/8/26 4:05:00 PM ET
    $SLP
    EDP Services
    Technology

    $SLP
    SEC Filings

    View All

    SEC Form DEFA14A filed by Simulations Plus Inc.

    DEFA14A - Simulations Plus, Inc. (0001023459) (Filer)

    2/4/26 4:10:05 PM ET
    $SLP
    EDP Services
    Technology

    SEC Form SCHEDULE 13G filed by Simulations Plus Inc.

    SCHEDULE 13G - Simulations Plus, Inc. (0001023459) (Subject)

    1/30/26 2:45:59 PM ET
    $SLP
    EDP Services
    Technology

    SEC Form 10-Q filed by Simulations Plus Inc.

    10-Q - Simulations Plus, Inc. (0001023459) (Filer)

    1/9/26 4:07:11 PM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Simulations Plus downgraded by BTIG Research

    BTIG Research downgraded Simulations Plus from Buy to Neutral

    12/18/25 9:02:23 AM ET
    $SLP
    EDP Services
    Technology

    TD Cowen initiated coverage on Simulations Plus with a new price target

    TD Cowen initiated coverage of Simulations Plus with a rating of Hold and set a new price target of $16.00

    9/30/25 8:58:03 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Simulations Plus from Overweight to Sector Weight

    7/15/25 8:39:07 AM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Leadership Updates

    Live Leadership Updates

    View All

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus

    QHP Capital, L.P. ("QHP"), an investor in technology and services companies in the life sciences and healthcare sectors, today announced its sale of Pro-ficiency, LLC ("Pro-ficiency" or the "Company"), a leader in providing tech-enabled training and compliance solutions for clinical trial investigators and site staff, to Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy. Michael Raymer, Chief Executive Officer of Pro-ficiency, said, "We are excited to join the Simulations Plus team, which has a well-established and recognized leadership position in modeling and simulations wi

    6/12/24 8:58:00 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer

    LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), announced today the appointment of Will Frederick as chief financial officer (CFO), succeeding John Kneisel, who retires after seven years with the company. Will Frederick brings more than 25 years of financial leadership experience to the company. He has a proven track record of developing and implementing strategies to drive revenue growth, increase profitability, managing merger & acquisition activities and achieving corporate objectives. He has global experience with both publicly traded and privately held companies including Pharsight, Entelos, Avaya, The Walt Disney Company and Ford Motor Company, among

    12/1/20 4:05:00 PM ET
    $DIS
    $SLP
    $F
    Services-Misc. Amusement & Recreation
    Consumer Discretionary
    EDP Services
    Technology

    $SLP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Simulations Plus Inc.

    SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

    8/8/24 2:18:03 PM ET
    $SLP
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

    SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

    2/13/24 5:13:58 PM ET
    $SLP
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

    SC 13G/A - Simulations Plus, Inc. (0001023459) (Subject)

    2/12/24 4:59:04 PM ET
    $SLP
    EDP Services
    Technology

    $SLP
    Financials

    Live finance-specific insights

    View All

    Simulations Plus Reports First Quarter Fiscal 2026 Financial Results

    Investor Day on January 21, 2026, to present new product vision and AI solutions Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported financial results for its first quarter fiscal 2026, ended November 30, 2025. First Quarter 2026 Financial Highlights (as compared to first quarter 2025) Total revenue decreased 3% to $18.4 million Software revenue decreased 17% to $8.9 million, representing 48% of total revenue Services revenue increased 16% to $9.5 million, representing 52% of total revenue Gross profit was $10.9 million and gross mar

    1/8/26 4:05:00 PM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date

    Conference call to be on Thursday, January 8, 2026, at 5 p.m. ET Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus", "SLP"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it will report first quarter fiscal 2026 financial results after the market close on Thursday, January 8, 2026. Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and prospective shareholders are invited to join the live webcast by registering here. The conference call can also be accessed by dialing 1-877-451-6152 (domestic) or 201-389-0879 (in

    12/17/25 7:50:00 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results

    Reaffirms fiscal 2026 revenue guidance of $79 to $82 million and adjusted diluted EPS guidance of $1.03 to $1.10  Investor Day on January 21, 2026, to present new product vision and AI solutions Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in cheminformatics, biosimulation, clinical operations solutions and medical communications that accelerate biopharma innovation, today reported financial results for its fourth quarter and fiscal 2025, ended August 31, 2025. Fourth Quarter 2025 Financial Highlights (as compared to fourth quarter 2024) Total revenue decreased 6% to $17.5 million Software revenue decreased 9% to $9.0 million, representi

    12/1/25 4:05:00 PM ET
    $SLP
    EDP Services
    Technology